RUNX1 and pulmonary arterial hypertension: Together, these findings support the hypothesis that aberrant pulmonary vascular remodeling in PAH may be due in part to imbalances in SOX17 and RUNX1 expression in EPCs that leads to suppression of endothelial differentiation and instead drives them toward a hematopoietic fate (Figure 12).